Global Glioblastoma Multiforme Treatment Market Size & Outlook
Global glioblastoma multiforme treatment market, 2021-2033 (US$M)
Related Markets
Global glioblastoma multiforme treatment market highlights
- The global glioblastoma multiforme treatment market generated a revenue of USD 4,041.0 million in 2025 and is expected to reach USD 7,867.4 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 8.7% by 2033.
- In terms of segment, surgery accounted for a revenue of USD 1,420.0 million in 2025.
- Tumor Treating Field (TTF) Therapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 4,041.0 million |
| Market revenue in 2033 | USD 7,867.4 million |
| Growth rate | 8.7% (CAGR from 2026 to 2033) |
| Largest segment | Surgery |
| Fastest growing segment | Tumor Treating Field (TTF) Therapy |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy (Bevacizumab), Tumor Treating Field (TTF) Therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 40.0% of the global glioblastoma multiforme treatment market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 88.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Glioblastoma Multiforme Treatment Market Scope
Glioblastoma Multiforme Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sumitomo Dainippon Pharma Oncology | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | https://www.sdponcology.com/ |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Arbor Pharmaceuticals | View profile | 501-1000 | Atlanta, Georgia, United States, North America | http://www.arborpharma.com |
| Karyopharm Therapeutics Inc | View profile | 325 | 85 Wells Avenue, 2nd Floor, Newton, MA, United States, 02459 | https://www.karyopharm.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Global glioblastoma multiforme treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 35.14% in 2025. Horizon Databook has segmented the Global glioblastoma multiforme treatment market based on surgery, radiation therapy, chemotherapy, targeted therapy (bevacizumab), tumor treating field (ttf) therapy covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Glioblastoma Multiforme Treatment Treatment Outlook (Revenue, USD Million, 2021-2033)
- Surgery
- Chemotherapy
- Temozolomide
- Lomustine
- Carmustine Wafers
- Other
- Radiation Therapy
- Targeted Therapy (Bevacizumab)
- Tumor Treating Field (TTF) Therapy
- Global Glioblastoma Multiforme Treatment End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Clinics / Outpatient Centers
- Ambulatory Surgical Centers
- Other
Reasons to subscribe to Global glioblastoma multiforme treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global glioblastoma multiforme treatment market databook
-
Our clientele includes a mix of glioblastoma multiforme treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global glioblastoma multiforme treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global glioblastoma multiforme treatment market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global glioblastoma multiforme treatment gbm market size, by regions, 2021-2033 (US$M)
Top 10 countries: Glioblastoma multiforme treatment gbm market size, 2023 (US$M)
Global glioblastoma multiforme treatment gbm market share, by end-use, 2023 & 2030 (%, US$M)
Glioblastoma multiforme treatment market: Opportunity assessment by country
Global glioblastoma multiforme treatment market, by region, 2025 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
